Cell line standards to reduce HER-2/neu assay variation and the potential of automated image analysis to provide more accurate cut points for predicting clinical response to trastuzumab.
我要评论
本期排行
- External quality assurance of ...
- Lymphoid neoplasms associated ...
- Composite B-cell and T-cell no...
- Platelet aggregation testing i...
- High prevalence of herpes simp...
- Cell line standards to reduce ...
- Using an AMACR (P504S)/34betaE...
- T-cell large granular lymphocy...
- Is cytomegalovirus associated ...
- EBV-associated B- and T-cell p...
共0条评论